AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.

Slides:



Advertisements
Similar presentations
Unstable angina and NSTEMI
Advertisements

Local improvement following national clinical audit workshops Auditing heart attacks Saving lives Dr Andrew Wragg Barts Health.
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI: The Mayo Clinic Protocol Henry H. Ting, MD, MBA Associate Professor of.
PPCI – National Update NCBC Workshop Jim McLenachan, National Clinical Lead for PPCI, NHS Improvement, England. London, 24 th November, NCBC Annual.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
ASE Event Slides  Major Trauma  Sepsis  QIPP 114 June 2010.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
Primary PCI Treatment of choice for Acute MI.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health PCI in the UK: Fit for service? A view from the Department.
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman.
What Do We Mean By Quality In PCI Institutional Requirements Dr Bernard Prendergast John Radcliffe Hospital, Oxford.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
ACS and Thrombosis in the Emergency Setting
Partner meeting Aprile, Alberto Cremonesi.
A modern thrombolysis service is superior to primary angioplasty
The impact of pre-hospital thrombolytic treatment on re-infarction rates: Analysis of the Myocardial Infarction National Audit project (MINAP) Dr Simon.
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
ACTION Registry-GWTG Results: January 1, 2009 – December 31, 2009.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
What’s happened in 2007 and why? Mark de Belder President British Cardiovascular Intervention Society.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
Advanced Angioplasty 2005 Primary PCI making it happen Data collection and Timings Peter Ludman University Hospital Birmingham.
Heart Attack Centres: Every Network Should Have (at least) One Dr Rod Stables The Liverpool Heart and Chest Hospital.
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
DGH v Tertiary Intervention Is there really a conflict? “The BCIS Perspective” Dr Martyn Thomas Kings College Hospital BCIS President.
Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham.
The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
West Hertfordshire Primary Angioplasty Service Masood Khan.
Pharmacotherapy in acute coronary syndromes Perspective from first line and regional hospitals in Czech Republic Cardionale, Petr Jansky.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Coronary Revascularisation: the DoH View Dr Roger Boyle National Director for Heart Disease.
PCI v CABG Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
Door to Balloon Time: Does it Matter? Tale of Two Studies.
Dr Martyn Thomas Kings College Hospital Primary angioplasty “A UK Experience” “The UK experience”
BCIS Audit Returns Adult Interventional Procedures Jan 2005 to Dec 2005 Peter F Ludman BCIS National Audit Officer On behalf of British Cardiovascular.
Agrément FMC N° Conflits d’intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos.
Blue light to the East of England Heart Attack Centres Dr Sarah Clarke Consultant Cardiologist And Clinical Director Cardiac Services Papworth Hospital.
Issued in 2014 – SCAAR. SCAAR Annual report 2013.
Issued in 2015 – RIKS-HIA. RIKS-HIA Annual report 2014.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
MINAP: MINAP: Equity of Access in the National Databases in Wales? Swansea University/ABMU, NICOR Swansea University/ABMU,
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
Associate Professor, Honorary Consultant Cardiologist
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Copyright © 2005 American Medical Association. All rights reserved.
Eva Kline-Rogers RN, NP, AACC University of Michigan
Heart Disease in the Acute Hospital
Has acute myocardial infarction mortality hit rock bottom
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
European Heart Association Journal 2007 April
Date: Presenter: Ryan Chen
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Primary PCI Monitoring Performance
Primary PCI Monitoring Performance
Global Registry of Acute Coronary Events: GRACE
Mid and South West Wales Primary Angioplasty update
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
DEScover: One-Year Clinical Results
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough

Disclosures/Conflicts of interest Research Grants –Cordis/Abbott Advisory Boards –Cordis/Boehringer Ingelheim

We do not have accurate data! We do not have precise figures for UK or for England & Wales on: –Numbers of MIs (in total), STEMIs and non-STEMIs –Numbers receiving lysis Numbers of these referred for rescue Numbers receiving interval PPCI –Numbers receiving PPCI –Numbers receiving no reperfusion therapy Possible sources of data: –Office for National Statistics –DoH HES data –CCAD: MINAP and BCIS datasets –National and International Registries

Trends in mortality from AMI from: Griffiths C, Brock A, Rooney C. Impact of introducing ICD-10 on trends in mortality from circulatory diseases in England & Wales. (adjusted from ICD-9 to ICD-10) A matter of coding? Better primary prevention? Better management of AMI? Better secondary prevention? Something in the air? All of the above?

GRACE Registry The Global Registry of Acute Coronary Events ST elevation audit reperfusion Carruthers KF et al, Heart 2005;91:290-8

MINAP Report 2005/06 Drug Therapy

Trends since 2001 Patients receiving Pre-Hospital Thrombolysis and PPCI

MINAP % John Birkhead, personal communication Lysis patients: 54% IHL and 68% PHL undergo subsequent angiography ?

BCIS CCAD data % of total, 4.6% of ACS 6.6% of total, 13.5% of ACS 48.7% 0.2%

BCIS CCAD data 2006 and 2007 data to date 2.3% of total, 4.6% of ACS 6.6% of total, 13.5% of ACS 48.7% 0.2% 54.4% 8.8% of total, 16.7% of ACS 2.7% of total, 4.9% of ACS 0.2%

Primary PCI – the experience UK population 60 million, at 500 pmp = 30,000 procedures pa 2004 data: Ludman

Primary PCI Routine Rx for STEMI 2006 data: Ludman NHS Centres only Working Hours24/7 Number of centres Working Hrs includes all 24/7 sites

Primary PCI for STEMI 2006 data from NHS Centres Total 3930 procedures 0 or No data CCAD E&W + Scot 2006 data: Ludman

UK Centres Angiography (90) PCI (91)

Distance from hub and expected distribution of STEMI cases

London results: Time to nearest hospital: drivetime zones

UK Centres PCI (91) NIAP sites

NIAP Project Main points from initial analysis BCS ASC, Glasgow, 2007 Compared with the patients treated with thrombolysis identified by these networks, the PPCI treated cohort: –Had a low in-hospital mortality –Involved fewer ambulance journeys –Had fewer complications (re-infarction, major and minor bleeds [inc. i-c bleeds]) –Were less likely to require additional angiography and revascularisation (PCI/CABG) during the index hospitalisation –Had a shorter length of stay

Median Door-to-Balloon times (minutes) BCS, Glasgow June 7, 2007

Median LOS [days] BCS, Glasgow June 7,

NIAP: Indications for PCI in lysis group

In-hospital Mortality (all patients) [Index hospitalisation PLUS “convalescent” hospital, includes shock] 62/139931/46764/378

All as % No.Success Partial success Fail no comp Re- PCI QMI Em CABG Death NSTEMI / UA no shock All STEMI no shock Primary PCI Rescue PCI Shock Outcome 2006 CCAD data only 2006 data: Ludman

p< (Unadjusted data)

p=0.06 (Unadjusted data)

p=0.017 (Unadjusted data)

p=0.004 (Unadjusted data)

Cardiac re-admissions and re-infarction

Readmission days Reperfusion strategy Total readmissions Readmissions per pt Readmissions per hospital survivor Total daysDays per ptDays per hospital survivor PPCI Lysis Nil

Additional procedures Given as procedures per pt as some patients had more than one procedure

Conclusions Need for more accurate data Whether you are a believer in PPCI or lysis + rescue, current activity is insufficient We will get better outcomes if we change our strategies Current data support a change to PPCI Regional organisation of “Heart Attack Centres” is essential Triage in the field, and direct transfer to labs is the only viable way to deliver PPCI, and is the best way to deliver PHL and timely rescue PCI STREAM will perhaps tell us what the options are for early presenters